A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Condition(s) studied
Investigational drug(s) / intervention(s)
Zasocitinib: Zasocitinib over-encapsulated tablets.
Active Comparator: Active comparator capsule.
Placebo: Zasocitinib or active comparator matching placebo.
Study summary
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).
The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modifying antirheumatic drugs.
The participants will be treated with either zasocitinib, active comparator, or placebo. Participants will be in the study for up to 60 weeks.
Eligibility
Primary outcome measure(s)
- Percentage of Participants Achieving American College of Rheumatology 20 (ACR20) Response at Week 16 for Zasocitinib Dose A and B Compared to Placebo — At Week 16
ACR responses are the numerical measurement of improvement in multiple disease assessment criteria. It is a composite clinical outcome assessment (COA) measure that includes both clinician-reported outcome assessments (ClinROs) and patient-reported outcomes (PROs). An ACR20 response is defined as: greater than or equal to (\>=) 20 percent (%) improvement from baseline in both swollen joint count 66 joints (SJC66) and tender joint count 68 joints (TJC68), and \>=20% improvement from baseline in 3 of the following 5 assessments: Patient's global assessment (PtGA) of psoriatic arthritis (PsA) pain; PtGA of PsA; physician's global assessment of disease activity (PGA) of PsA; participant's assessment of physical function as measured by health assessment questionnaire-disability index (HAQ-DI); high-sensitivity C-reactive protein (hsCRP). Percentage of participants achieving ACR20 response at Week 16 for zasocitinib Dose A and B compared to placebo will be reported.
Trial sites (184)
| Facility | City | Region | Status |
|---|---|---|---|
| AARR- Chandler AZ | Chandler | Arizona | |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Phoenix | Arizona | |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Phoenix | Arizona | |
| First OC Dermatology Research Inc. | Fountain Valley | California | |
| Purushotham & Akther Kotha MD | La Mesa | California | |
| Triwest Research Associates LLC | La Mesa | California | |
| The Cohen Medical Centers | Thousand Oaks | California | |
| Foothill Arthritis Clinic | Tujunga | California | |
| Medvin Clinical Research | Whittier | California | |
| Denver Arthritis Clinic | Denver, CO | Denver | Colorado | |
| Arthritis & Rheumatic Disease Specialties (AARDS) | Aventura | Florida | |
| RASF- Clinical Research Center | Boca Raton | Florida | |
| Clinical Research of West Florida | Clearwater, FL | Clearwater | Florida | |
| GNP Research, LLC | Hollywood, FL | Cooper City | Florida | |
| Driven Research LLC | Coral Gables | Florida | |
| Tectum Medical Research | Davie | Florida | |
| Sweet Hope Research Specialty, Inc, d/b/a Neoclinical Research | Hialeah | Florida | |
| Bioresearch Partners | Miami | Florida | |
| HMD Research LLC | Orlando | Florida | |
| Millennium Research | Ormond Beach, FL | Ormond Beach | Florida | |
| IRIS Research and Development | Plantation, FL | Plantation | Florida | |
| Sarasota Arthritis Research Center | Sarasota | Florida | |
| West Broward Rheumatology Associates, Inc. | Tamarac | Florida | |
| Clinical Research of West Florida | Tampa, FL | Tampa | Florida | |
| Marietta Rheumatology Associates | Marietta | Georgia | |
| GSCP/CIS | Orland Park | Illinois | |
| Greater Chicago Specialty Physicians LLC/CIS | Schaumburg | Illinois | |
| Accurate Clinical Research, Inc. | Lake Charles | Lake Charles | Louisiana | |
| Klein & Associates, M.D., P.A. | Hagerstown | Maryland | |
| Michigan Rheumatology Group, P.C. - Grand Blanc Office | Grand Blanc | Michigan | |
| Ash Research Clinic - Howell | Howell | Michigan | |
| June DO, PC Private Practice - Dr. Justus Fiechtner | Lansing | Michigan | |
| Clinical Research Institute of Michigan | Saint Clair Shores | Michigan | |
| Saint Louis Rheumatology | St Louis | Missouri | |
| Albuquerque Center for Rheumatology PC | Albuquerque | New Mexico | |
| Santa Fe Rheumatology | Santa Fe | New Mexico | |
| NYU Langone Health | Joseph S. and Diane H. Steinberg Ambulatory Care Center - Rheumatology Department | Brooklyn | New York | |
| Accellacare of Hickory | Hickory | North Carolina | |
| University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division | Cleveland | Ohio | |
| Paramount Medical Research & Consulting, LLC | Middleburg Heights | Ohio |
+ 144 more sites — see the full list on the official registry below.
More Takeda trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06671483 on ClinicalTrials.gov ↗ ← All trials in Germany